Although no significant cell death was observed under low levels of TBH treatment in human cancer cells, the combination of TBH treatment and p53 activation (e.g., Nutlin treatment) is able to effectively induce high levels of ferroptosis, even in ACSL4-null cells11. Here, ACSL4 is linked to cancer.